About Lkh innsbruck - univ. Klinikum innsbruck - Tiroler landeskrankenanstalten ges.m.b.h.; Innere Medizin
Das A.ö. Landeskrankenhaus - Universitätskliniken Innsbruck ist ein Krankenhaus in der Tiroler Landeshauptstadt Innsbruck und wird von der Tirol Kliniken GmbH geführt. Mit etwa 1550 Betten ist es eines der größten Krankenhäuser Österreichs.
Clinical Trials at Lkh innsbruck - univ. Klinikum innsbruck - Tiroler landeskrankenanstalten ges.m.b.h.; Innere Medizin
During the past decade, Lkh innsbruck - univ. Klinikum innsbruck - Tiroler landeskrankenanstalten ges.m.b.h.; Innere Medizin conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Lkh innsbruck - univ. Klinikum innsbruck - Tiroler landeskrankenanstalten ges.m.b.h.; Innere Medizin
According to Clinical.Site data, the most researched conditions in "Lkh innsbruck - univ. Klinikum innsbruck - Tiroler landeskrankenanstalten ges.m.b.h.; Innere Medizin" are
"Hepatitis C, Chronic" (1 trials), "Non-Squamous Non-Small Cell Lung Cancer" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Lkh innsbruck - univ. Klinikum innsbruck - Tiroler landeskrankenanstalten ges.m.b.h.; Innere Medizin" in a lesser frequency.
Clinical Trials Intervention Types at Lkh innsbruck - univ. Klinikum innsbruck - Tiroler landeskrankenanstalten ges.m.b.h.; Innere Medizin
Most popular intervention types in "Lkh innsbruck - univ. Klinikum innsbruck - Tiroler landeskrankenanstalten ges.m.b.h.; Innere Medizin" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Docetaxel" (1 trials), "Methotrexate" (1 trials), "Placebo to methotrexate" (1 trials) and "Placebo to tocilizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Lkh innsbruck - univ. Klinikum innsbruck - Tiroler landeskrankenanstalten ges.m.b.h.; Innere Medizin
The vast majority of trials in "Lkh innsbruck - univ. Klinikum innsbruck - Tiroler landeskrankenanstalten ges.m.b.h.; Innere Medizin" are
3 trials for "All" genders.
Clinical Trials Status at Lkh innsbruck - univ. Klinikum innsbruck - Tiroler landeskrankenanstalten ges.m.b.h.; Innere Medizin
Currently, there are NaN active trials in "Lkh innsbruck - univ. Klinikum innsbruck - Tiroler landeskrankenanstalten ges.m.b.h.; Innere Medizin".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Lkh innsbruck - univ. Klinikum innsbruck - Tiroler landeskrankenanstalten ges.m.b.h.; Innere Medizin,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Lkh innsbruck - univ. Klinikum innsbruck - Tiroler landeskrankenanstalten ges.m.b.h.; Innere Medizin, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".